NCT07185724View on ClinicalTrials.gov

Ketorolac Use and Fresh Embryo Transfer Outcomes

PHASE4RecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

October 1, 2027

Study Completion Date

September 1, 2028

Conditions
Infertility (IVF Patients)Infertility TreatmentPost-op PainFresh Embryo TransferOocyte Retrieval and Post Operative Pain Control
Interventions
DRUG

Ketorolac 30 mg IV

We will be evaluating the effect of post-oocyte retrieval ketorolac administration on clinical outcomes in fresh embryo transfer cycles.

Trial Locations (1)

52245

RECRUITING

UI Health Care Center for Advanced Reproductive Care, Iowa City

All Listed Sponsors
lead

Jessica D. Kresowik

OTHER